1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Bile Duct Obstruction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jewell, DP; Travis, SP | 1 |
| Chao, W; Levine, BA; Olson, MS; Zhou, W | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bile Duct Obstruction
| Article | Year |
|---|---|
The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
Topics: Adjuvants, Immunologic; Animals; Cholestasis; Colitis, Ulcerative; Crohn Disease; Diarrhea; Digestive System Physiological Phenomena; Enterocolitis, Pseudomembranous; Epithelium; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Hypertension, Portal; Ischemia; Microcirculation; Pancreatitis; Peptic Ulcer; Platelet Activating Factor | 1994 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Bile Duct Obstruction
| Article | Year |
|---|---|
Role of platelet-activating factor in hepatic responses after bile duct ligation in rats.
Topics: Animals; Azepines; Bile Ducts; Cholestasis; Diterpenes; Endotoxins; Ginkgolides; Kupffer Cells; Lactones; Ligation; Lipopolysaccharides; Liver; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles | 1992 |